Nvelop Therapeutics to Launch Dual Platforms for In Vivo Delivery of Next-Gen of Genetic Medicines
Nvelop Therapeutics has officially announced to develop the next generation of genetic medicines for a wide range of diseases.
Gene Therapy | 10/04/2024 | By Aishwarya | 267
NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004
NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.
Gene Therapy | 22/03/2024 | By Manvi | 149
Duchenne gene therapy trials resumed
Pfizer is set to resume its late-stage clinical trials of a treatment for Duchenne muscular dystrophy after stopping in December because of a clinical hold.
Gene Therapy | 02/05/2022 | By Sudeep Soparkar | 578
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy